| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| Cost of Revenue | $0 | -100.0% |
| Gross Profit | $0 | -100.0% |
| R&D Expense | $41.6M | +14.8% |
| SG&A Expense | $16.8M | +7.4% |
| Operating Income | -$58.4M | -12.9% |
| Net Income | -$53.5M | -5.9% |
| EPS (Basic) | -$1.88 | +1.6% |
| EPS (Diluted) | -$1.88 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $59.4M | -18.2% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $89.1M | -18.1% |
| Total Assets | $102.6M | -16.2% |
| Current Liabilities | $7.8M | -2.6% |
| Total Liabilities | $12.0M | -4.1% |
| Stockholders' Equity | $90.6M | -17.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$49.0M | -11.0% |
| Capital Expenditures | $343K | -53.8% |
| Investing Cash Flow | $7.3M | -82.6% |
| Financing Cash Flow | $28.4M | — |
| Free Cash Flow | -$49.3M | -10.0% |
| +1.1% |